The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2024

Filed:

Jun. 20, 2019
Applicant:

Ucb Biopharma Srl, Brussels, BE;

Inventors:

Pfrafulkumar Tulshibhai Chovatia, Oxfordshire, GB;

Rickki Lee Connelly, Oxfordshire, GB;

Richard Jeremy Franklin, Berkshire, GB;

Gregory William Haslett, Berkshire, GB;

Alistair James Henry, Berkshire, GB;

James Madden, Oxfordshire, GB;

Judi Charlotte Neuss, Berkshire, GB;

Timothy John Norman, Berkshire, GB;

Oliver Philps, Oxfordshire, GB;

William Ross Pitt, Berkshire, GB;

Konstantinos Rampalakos, Oxfordshire, GB;

Matthew Duncan Selby, Berkshire, GB;

Selvaratnam Suganthan, Oxfordshire, GB;

Giancarlo Trani, Oxfordshire, GB;

Zhaoning Zhu, Berkshire, GB;

Assignee:

UCB BIOPHARMA SRL, Brussels, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/14 (2006.01); C07D 333/50 (2006.01); C07D 333/78 (2006.01); C07D 409/04 (2006.01); C07D 409/06 (2006.01); C07D 409/12 (2006.01); C07D 413/04 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 487/04 (2006.01); C07D 495/04 (2006.01); C07D 495/10 (2006.01); C07D 498/10 (2006.01);
U.S. Cl.
CPC ...
C07D 409/14 (2013.01); C07D 333/50 (2013.01); C07D 333/78 (2013.01); C07D 409/04 (2013.01); C07D 409/06 (2013.01); C07D 409/12 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 487/04 (2013.01); C07D 495/04 (2013.01); C07D 495/10 (2013.01); C07D 498/10 (2013.01);
Abstract

Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.


Find Patent Forward Citations

Loading…